Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2378 (LINC02378) is a long intergenic non-protein coding RNA (lincRNA) gene that does not code for a protein but may contribute to gene regulatory mechanisms. Like other lincRNAs, it is part of a broad class of long non-coding RNAs (lncRNAs) implicated in orchestrating gene expression through diverse molecular interactions such as scaffolding chromatin modifiers, sponging microRNAs, or modulating transcription factors, though no specific mechanism or biological pathway has been described for LINC02378 to date. There is currently no evidence supporting its therapeutic targeting, biomarker status, or disease role.
None documented (no approved or experimental drugs known to act on this RNA)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2378 (LINC02378).